Clinical Trial Update: Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for MacuCLEAR MC-1101 in non-exudative age-related macular degeneration. The study is a Phase II/III trial and the current status is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• MacuCLEAR MC-1101 (MC-1101)

Snippet

Sponsor: MacuCLEAR, Inc. | Conditions: Non-Exudative Age Related Macular Degeneration | Phase 2, Phase 3 | Status: UNKNOWN